Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-29

Clinical Trial Update: Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease [NA]

View source ↗

Summary

AxioMed Spine Corporation is conducting a trial of the Freedom Cervical Disc for symptomatic cervical degenerative disc disease from C3 to C7; the current trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Freedom Cervical Disc

Snippet

Sponsor: AxioMed Spine Corporation | Conditions: Symptomatic Cervical Degenerative Disc Disease (DDD) From C3-C7 | NA | Status: UNKNOWN